Early seasonal coronavirus seroconversion did not produce cross-protective SARS-CoV-2 antibodies

J Infect. 2023 Jan;86(1):e10-e12. doi: 10.1016/j.jinf.2022.08.032. Epub 2022 Sep 5.

Abstract

Image, graphical abstract

Keywords: Antibodies; Coronavirus; Cross-neutralization; Seroconversion; Seroprevalence.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19*
  • Humans
  • SARS-CoV-2*
  • Seasons
  • Seroconversion
  • Seroepidemiologic Studies
  • Spike Glycoprotein, Coronavirus

Substances

  • Antibodies, Viral
  • Antibodies, Neutralizing
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2